On Friday, Institutional Shareholder Services (ISS), a prominent U.S.-based proxy advisory firm, issued a strong recommendation for investors of Keisei Electric Railway $9009.T to vote against six nominees for the company’s board of directors, including the current CEO. ISS’s stance aligns with UK-based activist investor Palliser Capital, which has long campaigned for governance improvements and capital reallocation at the Japanese railway operator. This development highlights increasing scrutiny by shareholders on management effectiveness and capital strategy in Japan’s public companies.

Sun Pharmaceutical Industries Ltd $SUNPHARMA.NS, the largest drugmaker in India by revenue, announced a significant leadership change on Friday. Kirti Ganorkar has been appointed as managing director, effective September 1, marking a strategic evolution in the company’s executive management. Meanwhile, Dilip Shanghvi, the founding leader who has been instrumental in shaping Sun Pharma’s growth, will continue to serve as executive director and chair the board, ensuring continuity in governance.

The International Finance Corporation (IFC), a member of the World Bank Group, has stepped up its financial support for Pakistan’s Reko Diq copper-gold mining project with an additional subordinated loan of $400 million. This commitment follows an earlier $300 million funding tranche announced in April, bringing IFC’s total financing to $700 million. The ambitious $6.6 billion project underscores the importance of international capital flows into resource infrastructure in emerging markets.